2008
DOI: 10.1002/art.23416
|View full text |Cite
|
Sign up to set email alerts
|

Autoantibody prevalence and lupus characteristics in a unique African American population

Abstract: Objective. The Gullah population of the Sea Islands of South Carolina is a unique group of African Americans who, due to geographic and cultural factors, remained isolated with minimal genetic admixture until the 1950s. Because of the unique homogeneous nature of the Gullah, we sought to define the genetic and environmental factors contributing to systemic lupus erythematosus (SLE) in this population.Methods. Using data from our ongoing cohort study of lupus in the Gullah population, which we established in 20… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
73
0

Year Published

2011
2011
2021
2021

Publication Types

Select...
8
1

Relationship

6
3

Authors

Journals

citations
Cited by 66 publications
(88 citation statements)
references
References 39 publications
6
73
0
Order By: Relevance
“…Taken together, data show that anti-NR2 antibodies can occur in up to 30% of patients with SLE 28 . Nevertheless, they are infrequent in the antibodiesence of detectable anti-dsDNA antibodies and their presence in the circulation is not associated with any of the 19 neuropsychiatric syndromes associated with SLE .…”
Section: Anti-n-methyl-d-aspartate (Nmda) Receptor Antibodiesmentioning
confidence: 52%
“…Taken together, data show that anti-NR2 antibodies can occur in up to 30% of patients with SLE 28 . Nevertheless, they are infrequent in the antibodiesence of detectable anti-dsDNA antibodies and their presence in the circulation is not associated with any of the 19 neuropsychiatric syndromes associated with SLE .…”
Section: Anti-n-methyl-d-aspartate (Nmda) Receptor Antibodiesmentioning
confidence: 52%
“…Recruitment was facilitated through the longitudinal observational SLE Clinic Database and SLE in Gullah Health Database (Kamen et al, 2008) and conducted by a research coordinator. To be eligible for participation in the study, participants had to meet the following inclusion criteria: (1) female, age 18 yr or older; (2) self-identification as African-American; (3) diagnosed with SLE and fulfilling at least four of the revised American College of Rheumatology classification criteria for SLE (Hochberg, 1997); (4) ambulatory; (5) experiencing fatigue for the past 3 mo or longer as indicated by a rating of at least 4 (moderate fatigue) on a Fatigue Visual Analog Scale ranging from 0 to 10, with 10 being the most fatigue (Piper et al, 2008); (6) sedentary (exercise <3 times per week for 30 min in the past 6 mo); (7) functionally literate (i.e., able to read and follow exercise directions in English); and (8) having permission from their physician to participate in the study.…”
Section: Participantsmentioning
confidence: 99%
“…The SLEIGH study has grown to include 237 patients with lupus, 166 unrelated controls and 220 family-member controls to date. Findings from SLEIGH to date suggest a higher than predicted prevalence of multiplex families, with 26.6 per cent of patients coming from multi-affected families, and a significantly lower age at lupus diagnosis in the offspring of a parent with lupus, which could be attributed to genetic ‘anticipation’ (Kamen et al 2008). There is also a high prevalence of autoantibody seropositivity in first-degree relatives of patients, with a notable 35 per cent of all SLEIGH first-degree relatives testing positive for antinuclear antibodies (ANA) at a significant titre of ≥ 1:120.…”
Section: Overview Of Community-engaged Research Approachmentioning
confidence: 99%
“…There is also a high prevalence of autoantibody seropositivity in first-degree relatives of patients, with a notable 35 per cent of all SLEIGH first-degree relatives testing positive for antinuclear antibodies (ANA) at a significant titre of ≥ 1:120. One of the investigations into potential environmental triggers of autoimmunity led to the discovery of an alarming 95 per cent prevalence of vitamin D deficiency among Gullah AAs, which subsequently led to further studies into the impact of vitamin D deficiency on immune and bone health (Ben-Zvi et al 2010; Kamen et al 2008). A clinical trial providing oral vitamin D to patients with SLE found that higher than expected doses of vitamin D are required to achieve normal levels, and that fortunately these doses are safe and well tolerated.…”
Section: Overview Of Community-engaged Research Approachmentioning
confidence: 99%